Clinical trials for Fibromyalgia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Fibromyalgia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Fibromyalgia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Fibromyalgia
Title Recruitment status Location
A EUROPEAN PHASE III, MULTICENTRE, DOUBLE-BLIND, RANDOMISED, MONOTHERAPY, 12-MONTH STUDY OF MILNACIPRAN FOR THE TREATMENT OF THE FIBROMYALGIA SYNDROME - FMS European Long-Term Study Authorised United Kingdom
A multicenter, multiple dose, double-blind, randomized, placebo-controlled, parallel group study of the safety and efficacy of AGN 203818 in female patients with fibromyalgia syndrome. Authorised United Kingdom
A EUROPEAN PHASE III, MULTICENTRE, DOUBLE-BLIND, RANDOMISED, MONOTHERAPY, 12-MONTH STUDY OF MILNACIPRAN FOR THE TREATMENT OF THE FIBROMYALGIA SYNDROME - FMS European Long-Term Study Authorised United Kingdom
A randomised, placebo-controlled, rising-dose crossover study to evaluate the effectiveness of modafinil in the management of fatigue in fibromyalgia - Modafinil and fibromyalgia Authorised United Kingdom
Duloxetine 60/120 mg Versus Placebo in the Treatment of Fibromyalgia Syndrome Authorised United Kingdom
A Clinical Trial Study of Quizartinib Administered in Combination with Induction and Consolidation Chemotherapy, and Administered as Maintenance Therapy in Subjects 18 to 75 Years Old with Newly Diagnosed Acute Myeloid Leukemia Authorised United Kingdom
This multi center Phase III clinical trial will evaluate impact of maintenance therapy (maintain the response achieved during the first course of treatment) with the FLT3 (FMS-like tyrosine kinase 3) inhibitor gilteritinib on the RFS (Relapse free survival) of participants with FLT3/ITD AML (FMS-like tyrosine kinase 3 / Internal tandem duplication Acute myeloid leukemia) who have successfully undergone allogeneic transplant. Authorised United Kingdom
A 14 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PREGABALIN TWICE DAILY IN PATIENTS WITH FIBROMYALGIA Authorised United Kingdom
THE EFFECT OF MILNACIPRAN 100MG BID ON SENSITIVITY TO STIMULUS-EVOKED PAIN IN PATIENTS WITH FIBROMYALGIA: A FMRI NEUROIMAGING STUDY - N/A Authorised United Kingdom
A Clinical Trial Study of Quizartinib (AC220) Administered in Combination with Induction and Consolidation Chemotherapy, and Administered as Maintenance Therapy in Subjects 18 to 75 Years Old with Newly Diagnosed Acute Myeloid Leukemia Authorised United Kingdom

Page last reviewed: 01/03/2016

Next review due: 01/03/2019